Glaucoma Research Foundation (GRF) has announced $720,000 in annual research grants to support 12 investigators at prestigious universities across the United States. The foundation is funding eight researchers at prominent medical research centers with one-year Shaffer Grants, in addition to four principal investigators engaged in the multi-year “Catalyst for a Cure” consortium.
GRF is awarding $100,000 to each of the Catalyst for a Cure researchers to continue their investigations toward identifying and testing specific biomarkers for glaucoma using advanced optical imaging technologies. Shaffer Grants in the amount of $40,000 each will be awarded to eight individual grant recipients to support innovative research into causes and potential new treatment targets for glaucoma.
GRF President and CEO, Thomas M. Brunner said, “Glaucoma Research Foundation invests in essential research to discover exactly how glaucoma causes vision loss, and to find ways to both prevent and potentially restore vision. 2018 is our 40th anniversary, and to date we have invested more than $60 million in innovative research and education. Our 2018 research grants are continuing that progress toward a cure and advancing our critical mission.”
This investment continues GRF’s status as one of the nation’s preeminent private sources of funding for innovative and collaborative glaucoma research.
